Jerome Benedict Durso

Chief Operating Officer, Intercept Pharmaceuticals.

Companies

Altimmune, Inc.President Mar 9, 2026 to now¹
Altimmune, Inc.Chief executive officer Dec 1, 2025 to now²
Altimmune, Inc.Board member Feb 25, 2025 to now³
Intercept PharmaceuticalsBoard member Jan 5, 2021 to Nov 13, 2023⁴
Intercept PharmaceuticalsChief executive officer Jan 5, 2021 to Nov 13, 2023⁴
Intercept PharmaceuticalsPresident Jan 5, 2021 to Jan 31, 2023⁴
Intercept PharmaceuticalsChief operating officer Feb 27, 2017 to Nov 25, 2020⁵

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

As of each latest filing. The line shows shares held over time.

Aug 13, 2026Bought 15,000 shares at $2.95 of Altimmune, Inc.⁶
Apr 1, 2026Bought 15,000 shares at $3.14 of Altimmune, Inc.⁸
Mar 6, 2026Bought 20,000 shares at $3.54 of Altimmune, Inc.⁹
Dec 22, 2025Bought 12,500 shares at $4.13 of Altimmune, Inc.¹⁰
Nov 8, 2023Returned to company 102,825 shares at $19.00 of Intercept Pharmaceuticals⁷
Nov 8, 2023U 51,815 shares at $19.00 of Intercept Pharmaceuticals⁷
Jan 27, 2023Granted 50,400 shares of Intercept Pharmaceuticals¹¹
Dec 31, 2022Shares withheld for tax 7,083 shares at $12.37 of Intercept Pharmaceuticals¹²
Jan 27, 2022Granted 35,700 shares of Intercept Pharmaceuticals¹³
Jan 1, 2022Shares withheld for tax 334 shares at $16.29 of Intercept Pharmaceuticals¹⁴
Dec 31, 2021Shares withheld for tax 5,607 shares at $16.29 of Intercept Pharmaceuticals¹⁴
Oct 1, 2021Shares withheld for tax 289 shares at $15.22 of Intercept Pharmaceuticals¹⁵

The numbers on this page point here. Each one links to the record it came from.